20 results on '"G. Geri"'
Search Results
2. Sudden Cardiac Arrest in Young Women
- Author
-
Orianne Weizman, Ardalan Sharifzadehgan, Wulfran Bougouin, Kumar Narayanan, Noémie Tence, Florence Dumas, Victor Waldmann, Lionel Lamhaut, Daniel Jost, Karim Wahbi, Olivier Varenne, Rodrigue Garcia, Nicole Karam, Alain Cariou, Xavier Jouven, Eloi Marijon, JM Agostinucci, V Algalarrondo, F Alla, C Alonso, W Amara, D Annane, C Antoine, P Aubry, E Azoulay, F Beganton, D Benhamou, C Billon, W Bougouin, J Boutet, C Bruel, P Bruneval, A Cariou, P Carli, E Casalino, C Cerf, A Chaib, B Cholley, Y Cohen, A Combes, JM Coulaud, M Crahes, D Da Silva, V Das, A Demoule, I Denjoy, N Deye, G Dhonneur, JL Diehl, S Dinanian, L Domanski, D Dreyfuss, D Duboc, JL Dubois-Rande, F Dumas, JP Empana, F Extramiana, M Fartoukh, F Fieux, M Gabbas, E Gandjbakhch, G Geri, B Guidet, F Halimi, P Henry, F Hidden Lucet, P Jabre, L Jacob, L Joseph, D Jost, X Jouven, N Karam, J Lacotte, F Lapostolle, K Lahlou-Laforet, L Lamhaut, A Lanceleur, O Langeron, T Lavergne, E Lecarpentier, A Leenhardt, N Lellouche, V Lemiale, F Lemoine, F Linval, T Loeb, B Ludes, A Maltret, N Mansencal, N Mansouri, E Marijon, J Marty, E Maury, V Maxime, B Megarbane, A Mekontso-Dessap, JP Mira, X Monnet, K Narayanan, N Ngoyi, MC Perier, O Piot, P Plaisance, I Plu, M Raux, F Revaux, JD Ricard, C Richard, B Riou, F Roussin, F Santoli, F Schortgen, A Sharifzadehgan, G Sideris, C Spaulding, JL Teboul, JF Timsit, P Tuppin, C Ursat, O Varenne, A Vieillard-Baron, S Voicu, K Wahbi, and V Waldmann
- Subjects
Adult ,medicine.medical_specialty ,Adolescent ,business.industry ,Sudden cardiac arrest ,medicine.disease ,Sudden cardiac death ,Young Adult ,Death, Sudden, Cardiac ,Physiology (medical) ,Internal medicine ,Cardiology ,Medicine ,Humans ,Female ,Prospective Studies ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business - Published
- 2021
3. Impact of Coronary Lesion Stability on the Benefit of Emergent Percutaneous Coronary Intervention After Sudden Cardiac Arrest
- Author
-
Louis Pechmajou, Eloi Marijon, Olivier Varenne, Florence Dumas, Frankie Beganton, Daniel Jost, Lionel Lamhaut, Eric Lecarpentier, Thomas Loeb, Jean-Marc Agostinucci, Georgios Sideris, Elisabeth Riant, Pierre Baudinaud, Albert Hagege, Wulfran Bougouin, Christian Spaulding, Alain Cariou, Xavier Jouven, Nicole Karam, F Adnet, V Algalarrondo, F Alla, C Alonso, W Amara, D Annane, C Antoine, P Aubry, E Azoulay, D Benhamou, C Billon, J Boutet, C Bruel, P Bruneval, P Carli, E Casalino, C Cerf, A Chaib, B Cholley, Y Cohen, A Combes, JM Coulaud, M Crahes, D Da Silva, V Das, A Demoule, I Denjoy, C Derkenne, N Deye, G Dhonneur, JL Diehl, S Dinanian, L Domanski, D Dreyfuss, D Duboc, JL Dubois-Rande, JP Empana, F Extramiana, M Fartoukh, F Fieux, B Frattini, M Gabbas, E Gandjbakhch, G Geri, B Guidet, F Halimi, P Henry, F Hidden-Lucet, P Jabre, L Jacob, L Joseph, D Journois, J Lacotte, K Lahlou-Laforet, A Lanceleur, O Langeron, T Lavergne, A Leenhardt, N Lellouche, V Lemiale, F Lemoine, F Linval, B Ludes, A Maltret, N Mansencal, N Mansouri, J Marty, E Maury, V Maxime, B Megarbane, A Mekontso-Dessap, JP Mira, X Monnet, N Ngoyi, MC Perier, O Piot, P Plaisance, I Plu, B Prunet, M Raux, F Revaux, JD Ricard, C Richard, F Roussin, F Santoli, F Schortgen, A Sharifzadehgan, JL Teboul, JF Timsit, P Tuppin, C Ursat, A Vieillard-Baron, S Voicu, K Wahbi, V Waldmann, Paris-Centre de Recherche Cardiovasculaire (PARCC (UMR_S 970/ U970)), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Necker - Enfants Malades [AP-HP], Hôpital Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Hôpital Raymond Poincaré [Garches], Hôpital Avicenne [AP-HP], Hôpital Lariboisière-Fernand-Widal [APHP], Service de Réanimation Médicale et Toxicologique [Hôpital Lariboisière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Lariboisière-Fernand-Widal [APHP], Optimisation thérapeutique en Neuropsychopharmacologie (OPTeN (UMR_S_1144 / U1144)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), and Mégarbane, Bruno
- Subjects
Male ,Time Factors ,medicine.medical_treatment ,Coronary Artery Disease ,030204 cardiovascular system & hematology ,Coronary angiogram ,Coronary Angiography ,[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract ,Coronary artery disease ,0302 clinical medicine ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Risk Factors ,Hospital Mortality ,Prospective Studies ,Registries ,Myocardial infarction ,[SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases ,[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases ,Middle Aged ,[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,[SDV.TOX] Life Sciences [q-bio]/Toxicology ,Treatment Outcome ,[SDV.TOX]Life Sciences [q-bio]/Toxicology ,[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Cardiology ,Female ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,Paris ,Acute coronary syndrome ,medicine.medical_specialty ,Clinical Decision-Making ,Risk Assessment ,Lesion ,03 medical and health sciences ,Percutaneous Coronary Intervention ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,Predictive Value of Tests ,Internal medicine ,medicine ,Humans ,Aged ,business.industry ,Percutaneous coronary intervention ,030208 emergency & critical care medicine ,Sudden cardiac arrest ,medicine.disease ,Heart Arrest ,Death, Sudden, Cardiac ,Conventional PCI ,[SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract ,Emergencies ,business - Abstract
Background: Conflicting data exist regarding the benefit of urgent coronary angiogram and percutaneous coronary intervention (PCI) after sudden cardiac arrest, particularly in the absence of ST-segment elevation. We hypothesized that the type of lesions treated (stable versus unstable) influences the benefit derived from PCI. Methods: Data were taken between May 2011 and 2014 from a prospective registry enrolling all sudden cardiac arrest in Paris and suburbs (6.7 million inhabitants). Patients undergoing emergent coronary angiogram were included. Decision to perform PCI was left to the discretion of local teams. We assessed the impact of emergent PCI on survival at discharge according to whether the treated lesion was angiographically unstable or stable, and we investigated the predictive factors for unstable coronary lesions. Results: Among 9265 sudden cardiac arrests occurring during the study period, 1078 underwent emergent coronary angiogram (median age: 59.6 years, 78.3% males): 463 (42.9%) had an unstable lesion, 253 (23.5%) only stable lesions, and 362 (33.6%) no significant lesions. Emergent PCI was performed in 478 patients (91.4% of unstable and 21.7% of stable lesions). At discharge, PCI of unstable lesions was associated with twice-higher survival rate compared with untreated unstable lesions (47.9% versus 25.6%, P =0.013), while stable lesions PCI did not improve survival (25.5% versus 26.3%, P =1.00). After adjustment, PCI of unstable coronary lesions was independently associated with improved survival (odds ratio, 2.09 [95% CI, 1.42–3.09], P P =0.824). Angina, initial shockable rhythm, ST-segment elevation, and absence of known coronary artery disease were independent predictors of unstable lesions. Conclusions: Emergent PCI of unstable lesions is associated with improved survival after sudden cardiac arrest, contrary to PCI of stable lesions. Accordingly, early PCI should only be performed in patients with unstable lesions. Four factors (chest pain, ST-elevation, absence of coronary artery disease history, and shockable initial rhythm) could help identify patients with unstable lesions who would, therefore, benefit from emergent coronary angiogram.
- Published
- 2020
4. Interleukin 21 Correlates with T Cell and B Cell Subset Alterations in Systemic Lupus Erythematosus
- Author
-
David Saadoun, Benjamin Terrier, David Klatzmann, M. Garrido, Patrice Cacoub, G. Geri, Nathalie Costedoat-Chalumeau, Lucile Musset, and Michelle Rosenzwajg
- Subjects
Adult ,Male ,Regulatory T cell ,T cell ,Immunology ,B-Lymphocyte Subsets ,T-Lymphocytes, Regulatory ,Interleukin 21 ,Rheumatology ,T-Lymphocyte Subsets ,medicine ,Humans ,Lupus Erythematosus, Systemic ,Immunology and Allergy ,Cytotoxic T cell ,IL-2 receptor ,B cell ,business.industry ,Interleukins ,ZAP70 ,Interleukin-17 ,Germinal Center ,Natural killer T cell ,medicine.anatomical_structure ,Female ,business - Abstract
Objective.Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by alterations of the B cell subset, global regulatory T cell (Treg) depletion, and an increase in Th17 cells. Interleukin 21 (IL-21) plays a critical role in T cell and B cell homeostasis. Our objective was to determine the implication of IL-21 and IL-21-producing CD4+ T cells in the pathogenesis of SLE.Methods.Twenty-five patients with SLE and 25 healthy donor controls were included. Analysis of CD4+ T cells producing IL-21, Th1, Th2, Th17, Treg, follicular helper T (TFH) cells, and B cells was performed in peripheral blood, and levels of cytokines were measured in culture supernatants.Results.Circulating CD4+ T cells producing IL-21 were markedly expanded in patients with SLE compared to controls and were correlated with increased Th17, decreased Treg, and increased memory B cells. CD4+ T cells producing IL-21 were composed of CXCR5+ and CXCR5–CD4+ T cell subsets. Both IL-21-producing CXCR5+CD4+ T cells and CXCR5–CD4+ T cells were increased in patients with SLE, the CXCR5–CD4+ subset correlating with Th17 cells and Treg, while the CXCR5+CD4+ subset was correlated with alterations of the B cell subset. The CXCR5+CD4+ subset comprised mainly circulating Bcl6+CXCR5+CD4+ TFH cells that were markedly expanded in patients with SLE and were correlated with increased circulating Bcl6+CXCR5+ germinal center B cells.Conclusion.These findings suggest that IL-21, produced by distinct cellular CD4+ T cells, correlates with alterations of T cell and B cell subsets in SLE, and that targeting IL-21 could provide beneficial effects on both T cell and B cell alterations.
- Published
- 2012
5. Th1 and Th17 cytokines drive inflammation in Takayasu arteritis
- Author
-
D, Saadoun, M, Garrido, C, Comarmond, A C, Desbois, F, Domont, L, Savey, B, Terrier, G, Geri, M, Rosenzwajg, D, Klatzmann, P, Fourret, P, Cluzel, L, Chiche, J, Gaudric, F, Koskas, and P, Cacoub
- Subjects
Adult ,Male ,Adolescent ,Giant Cell Arteritis ,Interleukin-23 ,Severity of Illness Index ,Interferon-gamma ,Young Adult ,Humans ,Glucocorticoids ,Aged ,Aged, 80 and over ,Inflammation ,Interleukin-6 ,Tumor Necrosis Factor-alpha ,Behcet Syndrome ,Interleukin-17 ,Receptors, Interleukin-1 ,Middle Aged ,Th1 Cells ,Takayasu Arteritis ,Case-Control Studies ,Cytokines ,Interleukin-2 ,Th17 Cells ,Female - Abstract
Takayasu arteritis (TAK) is a large-vessel vasculitis that induces damage to the aorta and its branches. Glucocorticoids remain the gold standard of therapy for TAK. The nature of the T cells driving vascular inflammation and the effects of glucocorticoids on the systemic components of TAK are not understood. The aim of this study was to analyze T cell homeostasis and cytokine production in peripheral blood and inflammatory lesions of the aorta in patients with TAK.T cell homeostasis and cytokine production in peripheral blood and inflammatory lesions of the aorta were analyzed using Luminex analysis, flow cytometry, and immunohistochemical analysis. The study included 41 patients fulfilling the American College of Rheumatology 1990 criteria for the classification of TAK (17 patients with active TAK and 24 patients with disease in remission), 30 patients with giant cell arteritis and 39 patients with Behçet's disease (disease controls), and 20 age- and sex-matched healthy control subjects.We observed a marked increase in the expression of Th1 and Th17 cells, which correlated with TAK disease activity. The addition of serum from patients with active TAK to sorted CD4+ T cells from healthy donors in culture medium induced significant production of interferon-γ (IFNγ) and interleukin-17A (IL-17A). We demonstrated the presence of IFNγ-, IL-6-, and IL-17A-producing T cells in vascular inflammatory infiltrates in patients with TAK. Corticosteroid therapy was associated with decreased levels of circulating Th1 cytokines in corticosteroid-treated patients with TAK compared with steroid-free patients with TAK (for IL-2, mean ± SD 5,079 ± 5,300 versus 7,359 ± 3,197 pg/ml; for IFNγ, 2,592 ± 3,072 versus 8,393 ± 3,392 pg/ml; for tumor necrosis factor α, 847 ± 724 versus 1,491 ± 392 pg/ml). However, glucocorticoids had essentially no effect on the frequency of Th17 cytokines (IL-1 receptor, IL-17, and IL-23).The Th17 and Th1 pathways contribute to the systemic and vascular manifestations of TAK. Glucocorticoid treatment suppresses Th1 cytokines but spares Th17 cytokines in patients with TAK.
- Published
- 2014
6. [Pathophysiology and management of post-cardiac arrest syndrome]
- Author
-
N, Mongardon, A, Bouglé, G, Geri, F, Daviaud, T, Morichau-Beauchant, R, Tissier, F, Dumas, and A, Cariou
- Subjects
Cross Infection ,Neuroprotective Agents ,Hypothermia, Induced ,Multiple Organ Failure ,Humans ,Shock ,Syndrome ,Nervous System Diseases ,Heart Arrest - Abstract
This review aims at providing an update on post-cardiac arrest syndrome, from pathophysiology to treatment.Medline database.All data on pathophysiology, clinical manifestations and therapeutic management, with focus on the publications of the 5 last years.Care of the patients after cardiac arrest is a medical challenge, in face of "post-cardiac arrest syndrome", which culminates into multi-organ failure. This syndrome mimics sepsis-related dysfunctions, with all clinical and biological manifestations related to the phenomenon of global ischemia-reperfusion. Acute cardiocirculatory dysfunction is usually controlled through pharmacological and mechanical support. Meanwhile, as a majority of cardiac arrest is related to myocardial infarction, early angiographic exploration should then be discussed when there is no obvious extracardiac cause, percutaneous coronary revascularization being associated with improved short and long-term prognosis. Therapeutic hypothermia is the cornerstone of neuroprotective armamentarium, beyond hemodynamic stabilization and metabolic maintenance.If ongoing evaluations should shed light on potential efficiency of new therapeutic drugs, a multidisciplinary approach of the post-cardiac arrest syndrome in expertise centre is essential.
- Published
- 2013
7. Low 25-hydroxyvitamin D serum levels correlate with the presence of extra-hepatic manifestations in chronic hepatitis C virus infection
- Author
-
Frédéric Jehan, Thierry Poynard, Jean-Claude Souberbielle, Patrice Cacoub, G. Geri, Mona Munteanu, David Saadoun, Damien Sène, and Benjamin Terrier
- Subjects
Male ,Hepatitis C virus ,T-Lymphocytes ,Rickets ,medicine.disease_cause ,Lymphocyte Activation ,vitamin D deficiency ,Virus ,Rheumatology ,medicine ,Vitamin D and neurology ,Humans ,Pharmacology (medical) ,Prospective Studies ,Vitamin D ,B-Lymphocytes ,business.industry ,Systemic Vasculitis ,Complement C4 ,Hepatitis C ,Hepatitis C, Chronic ,Middle Aged ,medicine.disease ,Vitamin D Deficiency ,Cryoglobulinemia ,Immunology ,Female ,Seasons ,business ,Vasculitis ,Systemic vasculitis - Abstract
Objective. Chronic HCV infection is associated with extra-hepatic manifestations. Recent studies have suggested an immunomodulatory role for vitamin D during HCV infection. We investigated the association between serum vitamin D status and the presence of HCV extra-hepatic manifestations. Methods. 25(OH)D serum levels were assessed in 94 HCV + RNA + patients [including 48 patients with mixed cryoglobulinaemia (MC) vasculitis]. Correlations between serum 25(OH)D levels and the presence of extra-hepatic manifestations of HCV infection were analysed. Results. Overall, 84 of 94 patients (89%) had hypovitaminosis D (430 ng/ml). Patients with vitamin D deficiency vs insufficiency vs sufficiency more frequently had systemic vasculitis (P=0.02), in particular purpura (P=0.006), detectable MC (P=0.008) and low C4 serum levels (P=0.006). Serum levels of 25(OH)D were also correlated with cryoglobulin and C4 levels and with marginal zone B cells and regulatory T cells. In multivariate analysis, the presence of MC and systemic vasculitis remained independently associated with low 25(OH)D levels. Conclusion. In chronic HCV infection, low 25(OH)D levels correlate with the presence of mixed cryoglobulinaemia and systemic vasculitis in chronic HCV infection. These findings suggest the potential multifaceted benefits of vitamin D supplementation in HCV-infected patients with extra-hepatic manifestations, but interventional studies are needed to confirm these data.
- Published
- 2012
8. Evolution of biomarkers of liver fibrosis and liver insufficiency in hepatitis C virus-infected patients treated with pegylated interferon plus ribavirin and rituximab
- Author
-
G, Geri, B, Terrier, F, Imbert-Bismut, D, Saadoun, D, Sène, T, Poynard, and P, Cacoub
- Subjects
Liver Cirrhosis ,Male ,Alanine Transaminase ,Hepacivirus ,Middle Aged ,Viral Load ,Antiviral Agents ,Antibodies, Monoclonal, Murine-Derived ,Treatment Outcome ,Ribavirin ,Hepatic Insufficiency ,Humans ,Female ,Interferons ,Prospective Studies ,Drug Monitoring ,Rituximab ,Biomarkers ,Aged - Abstract
Therapeutic options in hepatitis C virus (HCV)-related vasculitis may target the viral trigger using antiviral therapy [pegylated interferon plus ribavirin (PEG-IFN/RBV)], and/or the downstream B-cell arm of autoimmunity with rituximab (RTX). To date, no study has compared the efficacy of RTX combined with PEG-IFN/RBV on biomarkers of liver insufficiency in patients with severe liver fibrosis. Twenty-eight untreated HCV-related vasculitis patients with severe liver fibrosis (Metavir F3-F4) were included: 14 patients received RTX plus PEG-IFN/RBV and 14 patients PEG-IFN/RBV. The main clinical and biological data were recorded and compared at baseline, month 3 (M3), M12 and M24 of follow-up. Baseline epidemiological, clinical, virological and immunological features were similar between the groups. The virological response did not differ between cases and controls. The alanine aminotransferase (ALT) level and HCV viral load did not increase in patients treated with RTX. Serum albumin levels increased in patients treated with RTX at M3 and M6 (108% and 111% of baseline value; P = 0.06 and P = 0.13), whereas it was stable in patients treated without RTX. FibroTest values decreased from 0.70 at baseline to 0.59 at M3 (P = 0.5) and returned to 0.69 at M24 in the RTX-PEG-IFN/RBV group, whereas they were stable in the PEG-IFN/RBV group. RTX is safe in patients with severe HCV liver fibrosis and vasculitis. No beneficial effects of RTX were evidenced on liver fibrosis progression, but we found interesting correlations with the serum albumin level, FibroTest values and B-cell count.
- Published
- 2012
9. Spectrum of cardiac lesions in Behçet disease: a series of 52 patients and review of the literature
- Author
-
Patrice Cacoub, Du Le Thi Huong, G. Geri, Richard Isnard, M. Resche-Rigon, Jean-Charles Piette, Bertrand Wechsler, Zahir Amoura, and David Saadoun
- Subjects
Adult ,Male ,medicine.medical_specialty ,Myocarditis ,Endomyocardial fibrosis ,Myocardial Infarction ,Cohort Studies ,Pericarditis ,Aneurysm ,Sex Factors ,Internal medicine ,medicine ,Endocarditis ,Humans ,Myocardial infarction ,Heart Aneurysm ,Survival rate ,business.industry ,Behcet Syndrome ,Coronary Thrombosis ,Myocardium ,Anticoagulants ,General Medicine ,medicine.disease ,Endomyocardial Fibrosis ,Coronary arteries ,medicine.anatomical_structure ,Treatment Outcome ,cardiovascular system ,Cardiology ,Female ,business ,Colchicine ,Immunosuppressive Agents - Abstract
Cardiac abnormalities in patients with Behcet disease (BD) include pericarditis, myocarditis, endocarditis with valvular regurgitation, intracardiac thrombosis, endomyocardial fibrosis, coronary arteritis with or without myocardial infarction, and aneurysms of the coronary arteries or sinus of Valsalva. Data regarding the clinical spectrum, prevalence, and outcome of cardiac lesions in BD are lacking. In this study, we report the main characteristics, treatment, and long-term outcomes of 52 patients with cardiac lesions from a cohort of 807 (6%) BD patients. Forty-five (86.5%) patients were male, with a mean (±SD) age at BD diagnosis of 29.3 ± 10.3 years.Cardiac involvement was the first feature of BD in 17 (32.7%) patients. Cardiac lesions included pericarditis (n = 20; 38.5%), endocarditis (mostly aortic insufficiency) (n = 14; 26.9%), intracardiac thrombosis (n = 10; 19.2%), myocardial infarction (n = 9; 17.3%), endomyocardial fibrosis (n = 4; 7.7%) and myocardial aneurysm (n = 1; 1.9%). Patients with cardiac involvement were more frequently male (86.5% vs. 64.9%; p < 0.01) and had more arterial (42.3% vs. 11.1%; p < 0.01) and venous lesions (59.6% vs. 35.8%; p < 0.01) compared to those without cardiac manifestations. Factors associated with complete remission of cardiac involvement were treatment regimens with oral anticoagulants, immunosuppressants, and colchicine. The 5-year survival rate was 83.6% and 95.8% (p = 0.03) in BD patients with and without cardiac involvement, respectively. After a median (Q1-Q3) follow-up of 3.0 (1.75-4.2) years, 8 patients had died, in 3 cases directly related to cardiac involvement.In conclusion, cardiac lesions affected 6% of our large cohort of BD patients. The prognosis of cardiac involvement in BD is poor and improves with oral anticoagulation, immunosuppressive therapy, and colchicine.
- Published
- 2011
10. Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis
- Author
-
Michelle Rosenzwajg, Benjamin Terrier, Patrice Cacoub, G. Geri, Yves Allenbach, Olivier Benveniste, Wahiba Chaara, Lucile Musset, David Klatzmann, Adrien Six, David Saadoun, Nathalie Costedoat-Chalumeau, and Pierre Fouret
- Subjects
CD4-Positive T-Lymphocytes ,Male ,T cell ,Immunology ,Cell ,Giant Cell Arteritis ,Peripheral blood mononuclear cell ,Pathogenesis ,Interleukin 21 ,Rheumatology ,Interferon ,medicine ,Immunology and Allergy ,Humans ,Pharmacology (medical) ,Cells, Cultured ,Aged ,Aged, 80 and over ,business.industry ,Interleukins ,Middle Aged ,Th1 Cells ,medicine.disease ,Giant cell arteritis ,medicine.anatomical_structure ,Cytokines ,Th17 Cells ,Female ,Vasculitis ,business ,medicine.drug - Abstract
Objective Giant cell arteritis (GCA) is a large-vessel vasculitis of unknown origin. Recent findings indicate that at least 2 separate lineages of CD4+ T cells, Th1 and Th17 cells, participate in vascular inflammation. The pathways driving these T cell differentiations are incompletely understood, but may provide novel therapeutic targets. This study was undertaken to identify cytokines involved in the pathogenesis of GCA. Methods Thirty GCA patients fulfilling the American College of Rheumatology criteria, with active disease or disease in remission, and 30 age-matched controls were included. Levels of 27 cytokines were determined in culture supernatants, and flow cytometric analysis of peripheral blood mononuclear cells (PBMCs) and immunohistochemical analysis of temporal artery samples were performed. Results Multiparametric analysis of cytokines produced by PBMCs associated with GCA disease activity identified a signature involving interleukin-2 receptor (IL-2R), IL-12, interferon-γ (IFNγ), IL-17A, IL-21, and granulocyte–macrophage colony-stimulating factor (GM-CSF). An expansion of Th1 and Th17 cells and a decrease in Treg cells were observed in the peripheral blood of patients with active GCA. An expansion of IL-21–producing CD4+ T cells was also observed in patients with active GCA and correlated positively with Th17 and Th1 cell expansion. Immunohistochemical analysis revealed IFNγ, IL-17A, and IL-21 expression within inflammatory infiltrates. Stimulation of purified CD4+ T cells with IL-21 increased Th1 and Th17 cell frequencies and decreased FoxP3 expression. In contrast, blockade of IL-21 using IL-21R-Fc markedly decreased the production of IL-17A and IFNγ and increased FoxP3 expression. Conclusion Our findings indicate that IL-21 plays a critical role in modulating Th1 and Th17 responses and Treg cells in GCA, and might represent a potential target for novel therapy.
- Published
- 2011
11. New insights into the pathogenesis of Behçet's disease
- Author
-
Bertrand Wechsler, David Saadoun, Patrice Cacoub, G. Geri, and Marc Pineton de Chambrun
- Subjects
Inflammation ,business.industry ,T cell ,Behcet Syndrome ,Immunology ,Interleukin ,Receptors, Antigen, T-Cell, gamma-delta ,Behcet's disease ,Disease ,medicine.disease ,Pathogenesis ,Interleukin 10 ,medicine.anatomical_structure ,Immune system ,Recurrence ,T-Lymphocyte Subsets ,medicine ,HLA-B51 Antigen ,Immunology and Allergy ,Humans ,Genetic Predisposition to Disease ,business ,CD8 ,Autoantibodies - Abstract
Behcet's disease (BD) is a recurrent systemic inflammatory disorder of unknown origin characterized by oral and genital mucous ulcer, uveitis, and skin lesions. Involvement of large vessels, central nervous system (CNS), gastrointestinal tract and thrombotic events are less frequent but can be life threatening. The aim of this review is to provide new insights into the pathogenesis of BD. Over the past year substantial advances have been done in the understanding of the genetic [1,2] and immunology [3] of BD. BD is at the crossroad between autoimmune and autoinflammatory syndromes. In common with autoimmune diseases BD shares class I MHC association. However, in contrast to autoimmune disorders, BD has clinical features that seem to be mostly autoinflammatory. The pathogenesis of BD is still unknown, but major determinants of the genetic and immune system abnormalities have been reported recently. Triggering infectious factors are supposed to participate in the outbreak of BD in genetically predisposed patients. Two recent large genome-wide association study (GWAS) conducted in Turkey and Japan reported association between single nucleotide polymorphism (SNP) of interleukin (IL)-10 and IL-23R/IL-12RB2 genes and BD. New insights into the perturbations of T cell homeostasis of BD recently emerged. We have recently demonstrated the promotion of Th17 responses and the suppression of regulatory T cells (Tregs) that were driven by interleukin (IL)-21 production and that correlates with BD activity. Inflammatory cells within BD inflammatory lesions included mostly neutrophils, Th1 and Th17 cells, and cytotoxic CD8+ and γδ T cells. Altogether, the recent progresses in the knowledge of BD pathogenesis pave the way for innovative therapy.
- Published
- 2011
12. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease
- Author
-
Tu-Anh Tran, Patrice Cacoub, Danielle Seilhean, G. Geri, Bahram Bodaghi, Bertrand Wechsler, Vassili Soumelis, Michelle Rosenzwajg, Maxime Touzot, David Klatzmann, Lucile Musset, Benjamin Terrier, and David Saadoun
- Subjects
Adult ,Male ,Regulatory T cell ,Immunology ,Immunofluorescence ,medicine.disease_cause ,T-Lymphocytes, Regulatory ,Flow cytometry ,Autoimmunity ,Interleukin 21 ,Young Adult ,Cerebrospinal fluid ,medicine ,Immunology and Allergy ,Humans ,Aged ,Inflammation ,medicine.diagnostic_test ,business.industry ,Behcet Syndrome ,Interleukins ,Interleukin-17 ,FOXP3 ,Middle Aged ,Flow Cytometry ,Immunohistochemistry ,medicine.anatomical_structure ,Th17 Cells ,Female ,business ,Homeostasis - Abstract
Background Behcet disease (BD) is a chronic systemic inflammatory disorder of unknown etiology. Objective To determine the nature of T cells driving inflammatory lesions in BD. Methods T cell homeostasis and cytokines production were analyzed in peripheral blood and brain inflammatory lesions from 45 adult patients with BD (active and untreated BD [n = 25] and patients in remission [n = 20]) and 20 healthy donors, using Luminex, flow cytometry, immunohistochemistry, and immunofluorescence analysis. Results We found a marked increase in T H 17 cells and a decrease in the frequency of CD4 + forkhead box P3 + regulatory T cells (Tregs) in peripheral blood that were induced by IL-21 production and that correlate with BD activity. The addition of serum from patients with active BD in a sorted CD4 + T cells culture of healthy donors induced a significant and dose-dependent production of IL-17A and a decrease in forkhead box P3 expression. We demonstrated the presence of IL-21– and IL-17A–producing T cells within the cerebrospinal fluid, brain parenchyma inflammatory infiltrates, and intracerebral blood vessels from patients with active BD and central nervous system involvement. The stimulation of CD4 + T cells with IL-21 increased T H 17 and T H 1 differentiation and decreased the frequency of Treg cells. Conversely, IL-21 blockade with an IL-21R-Fc restored the T H 17 and Treg homeostasis in patients with BD. Conclusion We provided here the first evidence of the critical role of IL-21 in driving inflammatory lesions in BD by promoting T H 17 effectors and suppressing Treg cells. IL-21 represents a promising target for novel therapy in BD.
- Published
- 2011
13. Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis
- Author
-
Philippe Halfon, Stanislas Pol, Fabrice Carrat, Benjamin Terrier, Patrice Cacoub, G. Geri, Thierry Poynard, Jean-Claude Souberbielle, and Lionel Piroth
- Subjects
METAVIR Fibrosis Score ,Vitamin ,Adult ,Liver Cirrhosis ,Male ,medicine.medical_specialty ,Hepatitis C virus ,HIV Infections ,medicine.disease_cause ,Gastroenterology ,Antiviral Agents ,Severity of Illness Index ,chemistry.chemical_compound ,Internal medicine ,Antiretroviral Therapy, Highly Active ,Severity of illness ,Ribavirin ,medicine ,Vitamin D and neurology ,Prevalence ,Humans ,Vitamin D ,Immunodeficiency ,Hepatology ,business.industry ,Interferon-alpha ,Hepatitis C ,Hepatitis C, Chronic ,medicine.disease ,Vitamin D Deficiency ,chemistry ,Immunology ,Female ,Drug Monitoring ,business ,Biomarkers - Abstract
Background & Aims Recent findings in hepatitis C virus (HCV)-monoinfected patients have shown a correlation between low serum levels of 25-OH vitamin D3 [25(OH)D3] and severe liver fibrosis and low sustained virologic response to therapy. Data are lacking in HIV-HCV coinfected patients. Methods One hundred and eighty nine HIV-HCV coinfected patients, who received ⩾80% of interferon (IFN) plus ribavirin therapy, were analyzed for baseline serum 25(OH)D3 levels. Correlations between serum 25(OH)D3 levels, chronic hepatitis C features, HCV virologic response to antiviral therapy, and HIV infection characteristics were analyzed. Results Mean serum 25(OH)D3 level was 18.5±9.8ng/ml, including 162 (85%) patients with level ⩽30ng/ml. Serum 25(OH)D3 levels were significantly correlated with the histological Metavir fibrosis score ( r =−0.16; p =0.027). Patients with severe fibrosis (Metavir F3/F4) had lower serum 25(OH)D3 levels compared to F2 and F1 patients (16.2±10.0 vs. 18.9±8.5 and 20.9±11.1ng/ml, respectively; p =0.06). In multivariate analysis, low serum 25(OH)D levels were independently associated with severe liver fibrosis ( p =0.04) and cold season ( p =0.0002). Serum levels of 25(OH)D3 were also significantly correlated with liver fibrosis as assessed by FibroTest® ( r =−0.22; p =0.008) and serum α2-macroglobulin levels ( r =−0.23; p =0.006). In contrast, no correlation was found between 25(OH)D3 levels and HCV sustained virologic response to IFN-based therapy [OR 0.98 (0.95–1.01); p =0.22]. No association was found between 25(OH)D3 levels and markers of HIV-related immunodeficiency. Conclusions In HIV-HCV coinfected patients, low serum 25(OH)D3 levels correlate with severe liver fibrosis. In contrast, serum 25(OH)D3 levels are not linked to HCV virologic response to therapy or severity of immunodeficiency.
- Published
- 2010
14. [What's new in recurrent pericarditis in 2011?]
- Author
-
G, Geri and P, Cacoub
- Subjects
Aspirin ,Recurrence ,Acute Disease ,Disease Progression ,Humans ,Pericarditis ,Standard of Care ,Colchicine ,Algorithms - Abstract
Recurrent pericarditis are common and their management remains a matter of debate. Their precise pathophysiology is unclear, and both innate and adaptative immunity seem involved. An extensive work-up seeking for etiology seems to be unnecessary during the first episode of acute pericarditis, whereas it is mandatory in recurrent pericarditis. Despite extensive investigations, up to 80 % of recurrent pericarditis remains of unknown origin. Colchicin associated to non steroidal antiinflammatory drugs is the first line treatment whereas immunosuppressive drugs are exceptionally required.
- Published
- 2010
15. [Hepatic granulomas]
- Author
-
G, Geri and P, Cacoub
- Subjects
Granuloma ,Liver Diseases ,Decision Trees ,Humans - Abstract
Liver granulomas are histopathologically defined and associated with various liver and non-livers disorders. There are five main causes of liver granulomatosis: primary biliary cirrhosis, tuberculosis, sarcoidosis, B and C viral hepatitis, and drug related. In the other cases, not associated with an underlying systemic granulomatous disease, a systematic diagnostic approach should be used to identify less common etiologies. After a careful diagnostic work-up, a long-term follow-up of patients with undetermined liver granulomatosis is mandatory as it may be a presenting feature of liver lymphoma.
- Published
- 2010
16. [Liver involvement in systemic diseases]
- Author
-
G, Geri, D, Saadoun, and P, Cacoub
- Subjects
Sarcoidosis ,Liver Diseases ,Humans ,Vascular Diseases ,Connective Tissue Diseases - Abstract
Liver involvement is common in connective tissue disorders and usually asymptomatic. However, it may be symptomatic and cases of fulminant hepatitis have been reported. A diagnosis of specific hepatic involvement needs to rule out drug toxicity, viral hepatitis, or auto-immune liver disease. The large panel of auto-antibodies that is now available to the clinician is helpful to differentiate auto-immune hepatitis and specific liver involvement associated with connective tissue disease. In the latter, the outcome is generally favourable with immunosuppressive treatment.
- Published
- 2009
17. [Pneumococcal purulent pericarditis]
- Author
-
G, Geri, S, Dupeux, and J, Pouchot
- Subjects
Pleural Effusion ,Treatment Outcome ,Amoxicillin ,Humans ,Pericarditis ,Cardiomegaly ,Female ,Radiography, Thoracic ,Middle Aged ,Infusions, Intravenous ,Tomography, X-Ray Computed ,Pneumococcal Infections ,Anti-Bacterial Agents - Abstract
Purulent pneumoccocal pericarditis are extremely rare since the introduction of antibiotics.A 59-year-old woman presented to the emergency room with a seven-day history of dyspnea and fever. No signs of heart failure or cardiac friction rub were evidenced. Laboratory tests disclosed elevated acute phase reactants and elevated white blood cells with a high neutrophil count. Chest radiograph showed cardiomegaly and a bilateral pleural effusion. Chest-computed tomography confirmed the pleural effusion and evidenced a large pericardial effusion. Streptoccocus pneumoniae grew up form pericardial fluid and blood cultures. In addition to the pericardial drainage, the patient received intravenous amoxicillin therapy. Outcome was favourable. There was no evidence of immunodeficiency.Although exceptional, diagnosis of purulent pneumococcal pericarditis should not be missed as it may compromise vital prognosis. Therapy should combine pericardial drainage and antibiotics.
- Published
- 2007
18. [Computerized tomography in the study of degenerative ataxia]
- Author
-
DE MICHELE, GIUSEPPE, FILLA, ALESSANDRO, E. Mansi, L. Delehaye, S. Cirillo, G. D. Geronimo, G. Geri, G. Campanella, DE MICHELE, G, Filla, A, Mansi, E, Delehaye, L, Cirillo, Sossio, DI GERONIMO, G, Geri, G, Campanella, G., DE MICHELE, Giuseppe, Filla, Alessandro, E., Mansi, L., Delehaye, S., Cirillo, G. D., Geronimo, G., Geri, and G., Campanella
- Subjects
radiography, Tomography ,Cerebellar Ataxia ,classification/pathology/radiography, Humans, Spinocerebellar Degeneration ,Humans ,Tomography, X-Ray Computed ,X-Ray Computed ,Spinocerebellar Degenerations - Abstract
We describe the computerized tomography findings in 85 patients affected with degenerative ataxias. Cerebellar atrophy was moderate in patients with Friedreich's disease (no. 28) and early onset cerebellar ataxia with retained reflexes (no. 10) and, in Friedreich's disease, it was mostly a late feature. On the contrary, in symptomatic patients with adult onset dominant cerebellar ataxia (no. 24), cerebellar atrophy was always present and often marked. However, it was absent in 3 asymptomatic affected relatives. Infratentorial and supratentorial atrophy were frequent findings in idiopathic late onset cerebellar ataxia (no. 16).
- Published
- 1987
19. [Clinico-computer tomographic correlations in 3 cases of acute unilateral vascular lesions of the thalamus]
- Author
-
G, Andreani, G, Geri, and C, Simonetti
- Subjects
Male ,Cerebrovascular Disorders ,Thalamus ,Acute Disease ,Humans ,Female ,Middle Aged ,Tomography, X-Ray Computed - Published
- 1984
20. [1200 chalcolithic teeth: abrasion, caries, outer dimensions and X-ray appearance of the pulp chamber compared to 160 contemporary teeth]
- Author
-
E P, Geider, M, Fontaine, G, Geri, and J F, Montarnal
- Subjects
Paleodontology ,Radiography ,Tooth Abrasion ,Humans ,Odontometry ,Dental Caries ,Dental Pulp Cavity ,Tooth ,History, Ancient - Published
- 1984
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.